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Antibiofilm activity of trans-cinnamaldehyde, p-coumaric, and ferulic acids on
uropathogenic Escherichia coli
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Background/aim: Biofilm on urinary catheters results in persistent infections that are resistant to antibiotics. In this study, phytochemicals
were assessed as alternative antimicrobials in preventing and inactivating E. coli biofilm on urinary catheters.
Materials and methods: Biofilm prevention was tested using catheter fragments inoculated with E. coli and treated with transcinnamaldehyde, p-coumaric, and ferulic acids (0%, 0.1%, 0.25%, and 0.5%) for 0, 1, 3, and 5 days. Inactivation of E. coli biofilm with
the same agents at concentrations of 0%, 1%, 1.25%, or 1.5% used for 0, 1, 3, or 5 days was also evaluated.
Results: All used concentrations of trans-cinnamaldehyde prevented and effectively inactivated E. coli biofilm formed on urinary
catheter fragments. p-Coumaric (0.25% and 0.5%) and ferulic acids (0.5%) had preventive action on E. coli biofilm formation in urinary
catheter fragments. The number of uropathogenic E. coli cells in biofilm formed in the lumen of a urinary catheter was significantly
reduced in the presence of p-coumaric and ferulic acids, but complete inactivation of the biofilm formed was not observed, as opposed
to the use of trans-cinnamaldehyde.
Conclusion: The obtained results indicate that phytochemicals may be an important source of antibiofilm agents that have preventive
action on E. coli biofilm formation on urinary catheters.
Key words: Uropathogenic Escherichia coli, biofilm, cinnamic aldehyde, coumaric acid, ferulic acid

1. Introduction
Urinary tract infections (UTIs) are considered to be
the most common bacterial infection in patients with
a chronic indwelling bladder catheter, accounting for
an estimated 150 million cases per year worldwide (1).
Escherichia coli is the major factor in community-acquired
UTIs (70%–95%) and a large part of nosocomial UTIs
(50%), including cystitis, pyelonephritis, prostatitis, and
asymptomatic bacteriuria (2). Uropathogenic E. coli
(UPEC) is commonly isolated from biofilms formed on
both the internal and external urinary catheter surface
(3). In many cases, catheter-associated urinary tract
infections (CAUTIs) are asymptomatic, but when these
infections develop they are often difficult to treat and are
a major reservoir of resistant pathogens (4,5). Numerous
strategies to reduce the number of CAUTI cases have
been investigated, including the use of antibiotic-coated
or impregnated urinary catheters, but antibiotics could
only prevent CAUTIs during short-term catheterization
(6,7); in patients with long-term catheterization, the risk
* Correspondence: barbara.kot@uph.edu.pl

of bacteremia increases and antimicrobial treatment
may lead to the emergence of more antibiotic-resistant
bacteria (5). Therefore, there is a need for new strategies
to prevent UPEC biofilm on urinary catheters. Plants
have many chemical strategies to protect them from
microbial infections and different products of plant
origin are well known for their antimicrobial activities
(8). Phenolic products are common plant secondary
metabolites and can exhibit a wide range of biological
effects, including antimicrobial, antiinflammatory, and
anticarcinogenic action (9). Therefore, they are considered
potential therapeutic agents against inflammatory and
infectious diseases. Phenolic acids are a group of phenolic
compounds biosynthesized by the shikimate pathway and
include two classes: derivatives of benzoic acid (gallic acid)
and derivatives of cinnamic acid, such as p-coumaric acid
(p-CA) and ferulic acid (FA) (10). p-CA is present in large
quantities in many vegetables, fruits, and graminaceous
plants (11). FA is also a common phenolic compound
present in cereals and is esterified to hemicelluloses
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in the cell wall, while trans-cinnamaldehyde (TC) is
the principal component in cinnamon oil (12,13). The
chemical structures of TC, p-CA, and FA are shown in
Figure 1. Although the antibiofilm effect of TC on UPEC
was reported earlier (14,15), the efficiency of p-CA and FA
against UPEC biofilm formed on urinary catheters has not
been determined.
The aim of this study was to investigate TC, p-CA,
and FA as alternative antimicrobials in preventing and
inactivating UPEC biofilm on urinary catheters.
2. Materials and methods
2.1. Microorganism and growth media
E. coli clinical isolate was obtained from urine samples from
women with UTIs hospitalized in the neurological unit of
Wolomin District Hospital (Poland). E. coli UTI diagnosis
was made by clinical symptoms and by the presence of
≥105 colony-forming units (cfu) of E. coli per milliliter of
urine sample. Urine was inoculated onto 5% sheep blood
agar plate and Chrom ID CPS agar plate (bioMérieux,
France) in 10 µL aliquots and incubated at 37 °C overnight.
Five colonies that were coliform in morphology and were
lactose-fermenting were subcultured on sheep blood agar.
E. coli identification was performed according to standard
procedures (16). Finally, the identification of the isolate
was confirmed by using the ID 32 E system (bioMérieux).
The E. coli isolate was cultured in trypticase soy broth (TSB;
BBL, Becton Dickinson, USA) at 37 °C overnight. The
bacterial cells were sedimented by centrifugation (3600 ×
g, 10 min), washed with sterile PBS, and finally suspended
in TSB. The number of bacterial cells in suspension was
determined on TSA plates (BBL, Becton Dickinson).
2.2. Prevention of E. coli biofilm formation in the lumen
of urinary catheter
An all-silicone 20 FR Foley catheter (Romed, the Netherlands)
was cut into 3 cm fragments. Under sterile conditions, each
fragment was plugged with sterile pipette tips and heatsealed at one end, filled with bacterial suspension in TSB
(about 105 CFU/mL), and plugged with sterile pipette tips
at the other end, according to the method described by
Trautner et al. (17). The fragments with bacterial culture
were incubated at 37 °C for 2 h. Then the cultures were
removed and the catheter fragments were washed with

sterile PBS and transferred to 10 mL of TSB (control) and to
10 mL of TSB containing 0.1%, 0.25%, or 0.5% TC, p-PCA,
or FA (Sigma-Aldrich, Germany). After 0, 1, 3, and 5 days of
static incubation, the catheter fragments were washed with
PSB and two 1-cm segments were cut from each fragment.
Each segment of catheter was transferred to 1 mL of PSB
and sonicated at 40,000 Hz for 10 min in a water bath
sonicator (BL3-A, China) at 37 °C. The sonication liquid was
vortexed for 3 min and diluted in PSB. Subsequently, 100
µL of the sonication liquid and its dilutions were plated on
MacConkey agar (BBL, Becton Dickinson) to determine the
number of E. coli cells in the lumen of the urinary catheter
fragment. Two catheter fragments were used per treatment
and the experiment was repeated 3 times.
2.3. Inactivation of E. coli biofilm in the lumen of urinary
catheter
The catheter fragments were prepared as described above.
Incubation of catheter fragments with bacterial culture was
carried out at 37 °C for 5 days to allow biofilm formation
on the catheter luminal surface. Then the cultures were
removed and the catheter fragments were washed with
sterile saline. The catheter fragments were sealed at one
end and filled with saline (control), or saline with 1%,
1.25%, or 1.5% TC, p-CA, or FA. Then the other ends
were sealed and the samples were incubated at 37 °C. The
number of E. coli cells on the catheter’s luminal surface was
counted after 0, 1, 3, and 5 days of static incubation. For
this purpose, catheter fragments were washed with PSB
and each fragment was cut into two 1-cm segments that
were transferred to 1 mL PSB and sonicated as described
above. After vortexing the sonication liquid and diluting
it in PSB, 100 µL of the sonication liquid and its dilutions
were plated on MacConkey agar to determine the number
of E. coli cells. Two catheter fragments were used per
treatment and the experiment was repeated 3 times.
2.4. Statistical analysis
The data from three independent experiments were
analyzed by least-squares analysis of variance using the
general linear model procedure in SAS. Comparisons of
the group means and identification of differences were
performed using Duncan’s multiple-range test and SAS
software. A critical value of P ≤ 0.0001 was used for
analyses.
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Figure 1. Chemical structure of trans-cinnamaldehyde, p-coumaric acid, and ferulic
acid.
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3. Results
The effects of TC, p-CA, and FA were evaluated against the
E. coli biofilm on a urinary catheter. TC at a concentration
of 0.5% was highly effective for preventing E. coli biofilm
formation and after 1 day of incubation it completely
inhibited biofilm formation, while 0.1% and 0.25% TC
prevented biofilm formation after 3 days. A fully formed
biofilm (about 5.7 log cfu E. coli) in the lumen of the
control catheter with 0% TC was observed after 5 days
(Figure 2A). Incubation of E. coli biofilm with 1.25% and
1.5% TC solution completely inactivated biofilm after 1
day, while in the case of 1% TC, the amount of bacteria
in biofilm was above 2.1 log cfu. Total elimination of
E. coli biofilm with 1% TC was observed after 3 days of
incubation (Figure 2B).
p-CA at 0.5% and 0.25% prevented biofilm formation
after 3 and 5 days, respectively, while 0.1% p-CA after 5
days of incubation reduced the number of E. coli cells in
biofilm only to about 4.5 log cfu; the difference between
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this and the mean number of E. coli cells in the control
biofilm (about 5.8 log cfu) was not statistically significant
at P ≤ 0.0001 (Figure 3A). None of the p-CA concentrations
completely eliminated biofilm from the lumen of the
urinary catheter (Figure 3B). However, the mean numbers
of E. coli cells in the biofilm were lower (1.9–2.2 log cfu)
in the presence of p-CA concentrations compared to the
control biofilm (above 6.4 log cfu) and these differences
were highly statistically significant at P ≤ 0.0001. The mean
numbers of E. coli cells in biofilm treated with different
p-CA concentrations did not significantly differ at P ≤
0.0001.
After 5 days of incubation, 0.5% FA prevented E.
coli formation in biofilm. At 0.1% and 0.25% FA, mean
numbers of bacteria in biofilm after 1, 3, and 5 days of
incubation were not significantly different (P ≤ 0.0001)
but were highly significantly lower (P ≤ 0.0001) than in the
control biofilm (Figure 4A). E. coli biofilm was not fully
eliminated by FA (Figure 4B), but the average numbers
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Figure 2. E. coli biofilm prevention (A) and inactivation (B) in the lumen of a urinary catheter by trans-cinnamaldehyde (TC).
Biofilm formation prevention with 0% (diamonds), 0.1% (squares), 0.25% (triangles), and 0.5% (circles) TC (A); inactivation of
biofilm treated with 0% (diamonds), 1% (squares), 1.25% (triangles), and 1.5% (circles) TC solution in 0, 1, 3, and 5 days (B).
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Figure 3. E. coli biofilm prevention (A) and inactivation (B) in the lumen of a urinary catheter by p-coumaric acid (p-CA). Biofilm
formation prevention with 0% (diamonds), 0.1% (squares), 0.25% (triangles), and 0.5% (circles) p-CA (A); inactivation of biofilm
treated with 0% (diamonds), 1% (squares), 1.25% (triangles), and 1.5% (circles) p-CA solution in 0, 1, 3, and 5 days (B).
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Figure 4. E. coli biofilm prevention (A) and inactivation (B) in the lumen of a urinary catheter by ferulic acid (FA). Biofilm
formation prevention with 0% (diamonds), 0.1% (squares), 0.25% (triangles), and 0.5% (circles) (FA) (A); inactivation of biofilm
treated with 0% (diamonds), 1% (squares), 1.25% (triangles), and 1.5% (circles) FA solution in 0, 1, 3, and 5 days (B).

of E. coli cells that formed in biofilm in the presence of
different FA concentrations were highly significantly
lower (P ≤ 0.0001) than the average number in the control
biofilm (above 6.5 log cfu). The differences in numbers of
cells in the biofilm formed in the presence of different FA
concentrations were not significant at P ≤ 0.0001.
4. Discussion
Urinary catheterization is frequently used in the process
of treating of many diseases. CAUTI is the most common
infection acquired in hospitals and nursing homes
worldwide (5). The morbidity of the symptomatic bacterial
infection was found in 100% of patients after 30 days of
urinary catheterization (18). Biofilm formation on the
inner or outer surface of the urinary catheter plays a main
role in the pathogenesis of CAUTI and is a major reservoir
of resistant pathogens (6).
Different methods of CAUTI prevention have been
evaluated, including the use of catheters coated with
various materials targeted against the pathogenesis
of biofilms (19,20) or bladder and catheter irrigation
with antimicrobial solutions (1,14,21). Treatment with
prophylactic antibiotics is not recommended because
it is not always effective in preventing CAUTI and the
effect is only temporary. Moreover, continuous use of
antibiotics leads to the selection of strains that are resistant
to antibiotics (1). Effective alternative strategies to
decrease UPEC infections include the use of plant-derived
molecules that contain different functional groups in their
structure, because bacteria develop resistance to these
antimicrobials less frequently (22).
In this study, the activity of TC and phenolic acids
against UPEC biofilm on a urinary catheter was evaluated.
All used concentrations of TC prevented development of
UPEC biofilm on catheter fragments. Moreover, TC used
as an antimicrobial constituent in a catheter lock solution
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effectively inactivated already-formed E. coli biofilm. This
observation confirms the previous report by Amalaradjou
et al. (14), who showed that TC was effective against UPEC
biofilm on polystyrene or latex, and that the expression of
E. coli genes encoding attachment and invasion of bladder
cells was significantly decreased by TC (15). In our study,
p-CA had high activity in UPEC biofilm prevention. The
results showed that two concentrations (0.25% and 0.5%)
were effective in preventing E. coli biofilm formation
on the internal urinary catheter surface. The number of
UPEC cells in biofilm was also significantly reduced in
the presence of p-CA, but we did not observe complete
inactivation of the biofilm similar to the use of TC. Lou et
al. (23) reported that p-CA effectively inhibited the growth
of E. coli and other gram-negative bacteria by disrupting
bacterial cell membranes. p-CA also has the capacity to
bind bacterial genomic DNA, leading to cell death (23).
Alves et al. (24) demonstrated the antibacterial activity
of p-CA against fluoroquinolone-resistant E. coli isolated
from urine. However, the activity of p-CA against E. coli
biofilm, as far as we know, has not been investigated.
In this study we also evaluated the antibiofilm activity
of FA. Effective E. coli biofilm prevention was observed
only at the highest concentration (0.5%). When biofilm
formed in the presence of lower FA concentrations, E.
coli’s ability to form a biofilm decreased compared with
the control (in the absence of FA), but complete inhibition
of biofilm formation was not observed. The activity of FA
against E. coli biofilm formation on a microtiter plate was
evaluated by Borges et al. (25), who showed that FA had
no preventive effects on the biofilm formation ability of
E. coli; reduction of biofilm biomass in the presence of FA
was only 13% compared with the control.
We also evaluated the potential of FA to inactivate
existing biofilm on catheter fragments. FA showed high
potential to reduce the number of E. coli cells in biofilm
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formed on the internal urinary catheter surface, but
total biofilm removal was not achieved. Borges et al. (25)
observed a high reduction in E. coli biomass in biofilm on
microtiter plates with FA, but, similar to our results, total
elimination of biofilm was not obtained. It was found that
FA led to irreversible changes in membrane properties that
resulted in leakage of intracellular constituent (26).
Our results revealed that TC and two phenolic
acids had preventive action on biofilm formation on an
internal urinary catheter surface. TC at all concentrations
effectively prevented E. coli biofilm, while preventive
activity of phenolic acids depended on the concentration.
The effective preventive activity of p-CA was not observed
at the lowest concentration, whereas FA only blocked E.
coli formation at the highest concentration.
Among the applied antimicrobial agents, TC had the
highest potential to reduce the number of E. coli cells in
biofilm and completely removed biofilm from the urinary
catheter fragment. On the other hand, p-CA and FA were

effective in reducing the biofilm formed by E. coli, but
total elimination of biofilm was not observed. Different
activities of the evaluated phytochemicals may result
from their different chemical structures. The presence of a
CHO group in TC determines its high antibiofilm activity.
On the other hand, p-CA and FA are carboxylic acids
with a free OH group. The antibiofilm activity of these
acids was similar but lower compared to TC. This study
demonstrated the potential of the plant-derived molecules
to prevent and control UPEC biofilm on urinary catheter.
TC is the principal component of cinnamon oil and is an
effective antimicrobial product to prevent and inactivate
biofilm on catheters. p-CA and FA showed the potential
to prevent E. coli biofilm and seem to be promising as
antibacterial agents that may be used as catheter surface
coatings or as ingredients in catheter lock solutions to
prevent UTIs. However, research into the cytotoxic effects
of these phytochemicals on human bladder epithelial cells
at the tested concentrations is needed.
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